Funding Support and Author Disclosures Dr Tsimikas is co-inventor of and receives royalties from patents owned by University of California-San Diego for oxidation-specific antibodies and biomarkers related to oxidized lipoproteins and is a co-founder and has an equity interest in Oxitope and its affiliates as well as in Kleanthi Diagnostics. Although these relationships have been identified for conflict of interest management based on the overall scope of the project and its potential benefit to Oxitope and Kleanthi, the research findings included in this particular publication may not necessarily relate to the interests of Oxitope and Kleanthi. The terms of this arrangement have been reviewed and approved by the University of California-San Diego in accordance with its conflict of interest policies.